SOX4 and SMARCA4 upregulate glycolysis-driven tumor proliferation through Hexokinase 2 in Triple Negative Breast Cancer.

被引：0
|
作者：
Khanna, Pooja [1 ]
Mehta, Gaurav [1 ]
Bhatt, Vrushank [1 ]
Guo, Jessie Y. [1 ]
Gatza, Michael L. [1 ]
机构：
[1] CINJ, New Brunswick, NJ USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-035
引用
收藏
页数：1
相关论文
共 45 条
  • [1] SOX4 and SMARCA4 upregulate glycolysis-driven tumor proliferation through Hexokinase 2 in triple negative breast cancer.
    Khanna, Pooja
    Mehta, Gaurav
    Bhatt, Vrushank
    Guo, Jessie Y.
    Gatza, Michael L.
    CANCER RESEARCH, 2021, 81 (13)
  • [2] Sox4 and smarca4 upregulate glycolysis-driven tumor proliferation through hexokinase 2 in tnbc
    Khanna, Pooja
    Mehta, Gaurav
    Gatza, Michael L.
    CANCER RESEARCH, 2021, 81 (04)
  • [3] SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2
    Gaurav A. Mehta
    Steven P. Angus
    Christen A. Khella
    Kevin Tong
    Pooja Khanna
    Shelley A. H. Dixon
    Michael P. Verzi
    Gary L. Johnson
    Michael L. Gatza
    npj Breast Cancer, 7
  • [4] SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2
    Mehta, Gaurav A.
    Angus, Steven P.
    Khella, Christen A.
    Tong, Kevin
    Khanna, Pooja
    Dixon, Shelley A. H.
    Verzi, Michael P.
    Johnson, Gary L.
    Gatza, Michael L.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [5] TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2
    Zhou, Cixiang
    Wang, Difei
    Li, Jingchi
    Wang, Qiuyu
    Wo, Lulu
    Zhang, Xin
    Hu, Zhexuan
    Wang, Zheng
    Zhan, Mengna
    He, Ming
    Hu, Guohong
    Chen, Xiaosong
    Shen, Kunwei
    Chen, Guo-Qiang
    Zhao, Qian
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (39)
  • [6] MiR-630 inhibits cells migration and invasion by targeting SOX4 in triple-negative breast cancer
    Liu, Yun-Xiao
    Zhao, Li-Ping
    Zhang, Ya-Li
    Dong, Yan-Yan
    Ren, Hua-Yan
    Diao, Ke-Xin
    Mi, Xiao-Yi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9097 - 9105
  • [7] Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer
    Bagati, Archis
    Kumar, Sushil
    Jiang, Peng
    Pyrdol, Jason
    Zou, Angela E.
    Godicelj, Anze
    Mathewson, Nathan D.
    Cartwright, Adam N. R.
    Cejas, Paloma
    Brown, Myles
    Giobbie-Hurder, Anita
    Dillon, Deborah
    Agudo, Judith
    Mittendorf, Elizabeth A.
    Liu, X. Shirley
    Wucherpfennig, Kai W.
    CANCER CELL, 2021, 39 (01) : 54 - +
  • [8] Linking pBRD4 and PP2A inhibition in triple negative breast cancer.
    Pedregal, Manuel
    Cristobal, Ion
    Lobo, Francisco
    Izarzugaza, Yann
    Sanchez, Cristina Carames
    Moreno, Victor
    Hernandez, Tatiana
    Rubio, Jaime
    Zazo, Sandra
    Torrejon, Blanca
    Rojo, Federico
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] SMARCA4 Depletion Induces Cisplatin Resistance by Activating YAP1-Mediated Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer
    Kim, Jihyun
    Jang, Gyubeom
    Sim, Sung Hoon
    Park, In Hae
    Kim, Kyungtae
    Park, Charny
    CANCERS, 2021, 13 (21)
  • [10] Investigating anti-tumor immunity with CDK4/6 inhibition in triple negative breast cancer.
    Guo, Qiuchen
    Spasic, Milos
    Goreczny, Gregory
    Maynard, Adam
    McAllister, Sandra
    CANCER RESEARCH, 2021, 81 (13)
12345